UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling

Molecular psychiatry, 2018-04, Vol.23 (4), p.812-823

2018

Volltextzugriff (PDF)

A New Population-Enrichment Strategy to Improve Efficiency of Placebo-Controlled Clinical Trials of Antidepressant Drugs

Clinical pharmacology and therapeutics, 2010-11, Vol.88 (5), p.634-642

2010

Volltextzugriff (PDF)

Neural response to the observable self in social anxiety disorder

Psychological medicine, 2013-04, Vol.43 (4), p.721-731

2013

Volltextzugriff (PDF)

Model-Based Approach and Signal Detection Theory to Evaluate the Performance of Recruitment Centers in Clinical Trials With Antidepressant Drugs

Clinical pharmacology and therapeutics, 2008-09, Vol.84 (3), p.378-384

2008

Volltextzugriff (PDF)

Response to "Clinical Trials of Antidepressants: 'Enrichment Strategies'" and "The Placebo Response Is Part of Good Medicine"

Clinical pharmacology and therapeutics, 2011-04, Vol.89 (4), p.486-487

2011

Volltextzugriff (PDF)

Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat

Psychopharmacologia, 2002-03, Vol.160 (2), p.113-121

2002

Volltextzugriff (PDF)

Microarray analysis of cultured human brain aggregates following cortisol exposure: Implications for cellular functions relevant to mood disorders

Neurobiology of disease, 2006-09, Vol.23 (3), p.630-636

2006

Volltextzugriff (PDF)

Pharmacokinetics and time-course of D2 receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients

Journal of psychopharmacology (Oxford), 2008-11, Vol.22 (8), p.882-894

2008

Volltextzugriff (PDF)

Apolipoprotein E Expression by Neurons Surviving Excitotoxic Stress

Neurobiology of disease, 1999-12, Vol.6 (6), p.508-514

1999

Volltextzugriff (PDF)

rKv1.2 overexpression in the central medial thalamic area decreases caffeine‐induced arousal

Genes, brain and behavior, 2011-11, Vol.10 (8), p.817-827

2011

Volltextzugriff (PDF)

Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels

The Journal of neuroscience, 1996-04, Vol.16 (8), p.2495-2507

1996

Volltextzugriff (PDF)

Appetite-suppressing effects on urocortin, a CRF-related neuropeptide

Science (American Association for the Advancement of Science), 1996-09, Vol.273 (5281), p.1561-1564

1996

Volltextzugriff (PDF)

Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor

Gene therapy, 1998-09, Vol.5 (9), p.1213-1220

1998

Volltextzugriff (PDF)

Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop

Molecular psychiatry, 2011-11, Vol.16 (11), p.1064-1066

2011

Volltextzugriff (PDF)

Molecular mechanisms of the positive reinforcing effect of nicotine

Behavioural pharmacology, 1999-11, Vol.10 (6-7), p.587-596

1999

Volltextzugriff (PDF)

P.0419 chronic exposures to high concentration cortisol disrupt structural plasticity in human iPSC-derived dopaminergic neurons

European neuropsychopharmacology, 2021-12, Vol.53, p.S304-S305

2021

Volltextzugriff (PDF)

Distribution of the messenger RNA for the small conductance calcium-activated potassium channel SK3 in the adult rat brain and correlation with immunoreactivity

Neuroscience, 2001-01, Vol.102 (1), p.209-215

2001

Volltextzugriff (PDF)

Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats

The Journal of pharmacology and experimental therapeutics, 1996-01, Vol.276 (1), p.56

1996

Volltextzugriff (PDF)

S54 USE OF PRECLINICAL DRUG PROFILE IN CLINICAL SETTINGS FOR NOVEL COMPOUNDS IN DEPRESSION

Behavioural pharmacology, 2005-09, Vol.16 (Supplement 1), p.S17

2005

Volltextzugriff (PDF)

Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor

Neuroscience, 1996-09, Vol.74 (2), p.303-311

1996

Volltextzugriff (PDF)

P.1.g.011 - Ketamine and pramipexole promote structural plasticity in human iPSC-derived dopaminergic neurons via D3 receptor and mTOR pathway

European neuropsychopharmacology, 2017-10, Vol.27, p.S644-S644

2017

Volltextzugriff (PDF)

Ketamine and pramipexole promote structural plasticity in human iPSC-derived dopaminergic neurons via D3 receptor and mTOR pathway

European neuropsychopharmacology, 2017-10, Vol.27, p.S644

2017

Volltextzugriff (PDF)

P.021 Social dysfunction in mood disorders and schizophrenia: clinical correlates in four independent samples

European neuropsychopharmacology, 2019-12, Vol.29, p.S34-S35

2019

Volltextzugriff (PDF)

S.26.04 The role of the D3 dopamine receptor in stimulant dependence: studies in humans with pharmacological fMRI

European neuropsychopharmacology, 2008, Vol.18, p.S195-S195

2008

Volltextzugriff (PDF)

P.1.g.093 - Ketamine promotes plasticity in mouse-primary and human-iPSC-derived dopaminergic neurons via D3R and mTOR signalling

European neuropsychopharmacology, 2016-10, Vol.26, p.S268-S269

2016

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(91)
Life Sciences & Biomedicine
(87)
Animals
(75)
Male
(69)
Biological And Medical Sciences
(63)
Rats
(61)
Neurosciences & Neurology
(57)
Neurosciences
(55)
Medical Sciences
(34)
Humans
(33)
Fundamental And Applied Biological Sciences. Psychology
(29)
Pharmacology & Pharmacy
(26)
Female
(25)
Psychiatry
(21)
Psychology. Psychoanalysis. Psychiatry
(21)
Rats, Wistar
(21)
Adult
(20)
Rat
(19)
Pharmacology. Drug Treatments
(18)
Rats, Inbred Strains
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling

A New Population-Enrichment Strategy to Improve Efficiency of Placebo-Controlled Clinical Trials of Antidepressant Drugs

Neural response to the observable self in social anxiety disorder

Model-Based Approach and Signal Detection Theory to Evaluate the Performance of Recruitment Centers in Clinical Trials With Antidepressant Drugs

Response to "Clinical Trials of Antidepressants: 'Enrichment Strategies'" and "The Placebo Response Is Part of Good Medicine"

Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat

Microarray analysis of cultured human brain aggregates following cortisol exposure: Implications for cellular functions relevant to mood disorders

Pharmacokinetics and time-course of D2 receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients

Apolipoprotein E Expression by Neurons Surviving Excitotoxic Stress

rKv1.2 overexpression in the central medial thalamic area decreases caffeine‐induced arousal

Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels

Appetite-suppressing effects on urocortin, a CRF-related neuropeptide

Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor

Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop

Molecular mechanisms of the positive reinforcing effect of nicotine

P.0419 chronic exposures to high concentration cortisol disrupt structural plasticity in human iPSC-derived dopaminergic neurons

Distribution of the messenger RNA for the small conductance calcium-activated potassium channel SK3 in the adult rat brain and correlation with immunoreactivity

Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats

S54 USE OF PRECLINICAL DRUG PROFILE IN CLINICAL SETTINGS FOR NOVEL COMPOUNDS IN DEPRESSION

Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor

P.1.g.011 - Ketamine and pramipexole promote structural plasticity in human iPSC-derived dopaminergic neurons via D3 receptor and mTOR pathway

Ketamine and pramipexole promote structural plasticity in human iPSC-derived dopaminergic neurons via D3 receptor and mTOR pathway

P.021 Social dysfunction in mood disorders and schizophrenia: clinical correlates in four independent samples

S.26.04 The role of the D3 dopamine receptor in stimulant dependence: studies in humans with pharmacological fMRI

P.1.g.093 - Ketamine promotes plasticity in mouse-primary and human-iPSC-derived dopaminergic neurons via D3R and mTOR signalling

Suchergebnisse filtern